Andromeda 2025 Financial Report Analysis: Adjusted net profit turns profitable to $28 million, net loss narrows by 64% year-over-year

Operating Revenue: Full-Year Slight Decline, Regional Structure Shows Clear Divergence

In 2025, Adama’s full-year sales revenue was $4.051 billion, down 2% year over year. This was mainly affected by a 2% decline in selling prices driven by an oversupply of technical-grade active ingredients and low prices for bulk agricultural commodities, while full-year sales volumes remained broadly flat. By region, performance varied significantly across segments:

North America became the only region to achieve double-digit growth, with full-year sales revenue up 11% year over year, mainly benefiting from the launch of the new product CAZADO™ that drove growth in the agrochemical business’s sales volumes. The Asia-Pacific region, however, saw full-year sales revenue fall 11% year over year due to factors including the contraction of non-agricultural business in China and extreme weather in India. China’s full-year sales revenue was $464 million, down 5% year over year, mainly due to the strategic decision to cease selling some basic chemical products.

In the fourth quarter, the company’s sales revenue was $1.026 billion, down 8% year over year. Of this, sales volume decreased by 8%. The core reason was that the company proactively reduced its sales of basic chemical products, coupled with changes in sales cadence caused by customers’ “just-in-time procurement” model.

Net Profit: Net Loss Narrows Significantly, Adjusted Results Turn Profitable

For full-year 2025, reported net loss was $147 million, narrowing by 64% year over year from the $407 million net loss in 2024. Adjusted net profit turned from loss to profit to $28 million, while the same period in 2024 was a net loss of $206 million, representing a qualitative improvement.

In the fourth quarter, reported net loss was $88 million, narrowing by 41% from the $149 million net loss in the same period of 2024. Adjusted net loss was only $10 million, narrowing significantly by 98% year over year.

Non-GAAP Net Profit: Corresponding Adjusted Profit Metrics

The adjusted net profit disclosed by the company can be mapped to the non-GAAP net profit basis. In full-year 2025, adjusted net profit was $28 million, turning from loss to profit; in the same period of 2024, it was a net loss of $206 million. In the fourth quarter, adjusted net loss was $10 million, narrowing significantly from the $58 million net loss in the same period of 2024.

Basic Earnings per Share: Loss Magnitude Narrows Significantly

For full-year 2025, reported basic earnings per share was -$0.0631 (RMB -0.4488). In the same period of 2024, it was -$0.1749 (RMB -1.2461). The loss magnitude narrowed significantly. In the fourth quarter, reported basic earnings per share was -$0.0378 (RMB -0.2674). In the same period of 2024, it was -$0.0639 (RMB -0.4572).

Non-GAAP Earnings per Share: Adjusted Metrics Near Breakeven

Adjusted basic earnings per share corresponds to non-GAAP earnings per share. For full-year 2025, it was $0.0122 (RMB 0.0875), achieving a positive result. For the fourth quarter, it was -$0.0005 (RMB -0.0035), close to breakeven. In the same period of 2024, it was -$0.0247 (RMB -0.1767).

Expenses: Strong Results in Overall Cost Control

For full-year 2025, reported operating expenses were $885 million, down $106 million year over year. As a percentage of sales revenue, the ratio fell from 23.9% to 21.8%. In the fourth quarter, reported operating expenses were $249 million, down $71 million year over year. As a percentage of sales revenue, the ratio fell from 28.7% to 24.3%. The decrease in expenses mainly benefited from improved operating efficiency under the “Advancement” transformation plan. At the same time, spending on non-operating items decreased from $230 million in 2024 to $113 million, a significant reduction.

Adjusted operating expenses for the full year were $863 million, up slightly by $13 million year over year. This was mainly due to impacts from employee performance-based compensation and foreign-exchange fluctuations, as well as an allowance provision for credit losses by Latin American distributors. In addition, cost optimization under the “Advancement” plan partially offset the above increase.

Selling Expenses: Scale Largely Flat; Expense Ratio Slightly Up

For full-year 2025, adjusted selling expenses were $640 million, compared with $652 million in the same period of 2024; the scale was basically unchanged. As a percentage of sales revenue, the ratio rose from 15.7% in 2024 to 15.8%. In the fourth quarter, adjusted selling expenses were $166 million, compared with $153 million in the same period of 2024, up 8.5% year over year. As a percentage of sales revenue, the ratio rose from 13.7% to 16.2%, mainly due to business expansion and spending on market activities.

Administrative Expenses: Up Year over Year; Expense Ratio Slightly Higher

For full-year 2025, adjusted administrative expenses were $155 million, compared with $141 million in the same period of 2024, up 9.9% year over year. As a percentage of sales revenue, the ratio rose from 3.4% to 3.8%. In the fourth quarter, adjusted administrative expenses were $41 million, compared with $40 million in the same period of 2024, up 2.5% year over year. As a percentage of sales revenue, the ratio rose from 3.6% to 4.0%, mainly due to compensation and operating expenses after optimization of the management structure.

Finance Costs: Down Year over Year; Cost Control Shows Results

For full-year 2025, adjusted finance costs were $261 million, compared with $285 million in the same period of 2024. They decreased by $24 million year over year, a drop of 8.4%. In the fourth quarter, adjusted finance costs were $58 million, compared with $61 million in the same period of 2024. They decreased by $3 million year over year, a drop of 4.9%. The decrease in finance costs mainly benefited from the optimization of the debt structure through bond buybacks by subsidiaries, lower hedging costs due to hedging of the Israeli shekel exchange rate, and a narrowing of the risk exposure of the Turkish lira.

R&D Expenses: Continued Stable Investment Supporting Product Innovation

For full-year 2025, adjusted R&D expenses were $59 million, compared with $58 million in the same period of 2024, a slight increase of 1.7% year over year. In the fourth quarter, R&D expenses were $17 million, compared with $13 million in the same period of 2024, up 30.8% year over year. Continued R&D investment supported the expansion of the product pipeline. In full-year 2025, the company launched 139 new products in total. In the fourth quarter as well, the company rolled out multiple differentiated products such as EDAPTIS® and BELLALI®, while obtaining new product registrations in multiple locations globally.

R&D Personnel: Relevant Details Not Disclosed

(Note: The original text does not mention details such as the number of R&D personnel, compensation, composition, etc., so no interpretation is provided.)

Cash Flow: Operating Cash Flow Improves; Free Cash Flow Increases

Overall cash flow performance improved for the full year 2025. Both operating cash flow and free cash flow increased year over year. Cash flows from investing activities were basically stable, while cash outflows from financing activities narrowed year over year.

Cash Flow from Operating Activities: Improved Year over Year; Better Cash Collection Capability

For full-year 2025, net cash flow generated from operating activities was $567 million, compared with $528 million in the same period of 2024, an increase of $39 million year over year. In the fourth quarter, it was $237 million, compared with $126 million in the same period of 2024, a significant increase of 88.1% year over year. The key reason for the growth in cash flow was that the company strengthened cash collection management, improved accounts receivable collection efficiency, and offset the cash consumption caused by increased procurement.

Cash Flow from Investing Activities: Strategic Focus on Core Areas

For full-year 2025, net cash flow from investing activities was -$169 million, compared with -$162 million in the same period of 2024, basically flat. In the fourth quarter, it was -$38 million, compared with -$40 million in the same period of 2024, with slightly reduced cash outflows. The company prioritized deploying funds into key infrastructure, product lines, and innovation businesses, while optimizing existing assets. In the second quarter, payments or contingent consideration for its controlling subsidiary AgriNova was the main incremental item driving full-year investment cash outflows.

Cash Flow from Financing Activities: Debt Optimization; Cash Outflows Narrow

For full-year 2025, net cash flow from financing activities was -$422 million, compared with -$556 million in the same period of 2024. Cash outflows narrowed by 24.1% year over year. In the fourth quarter, it was -$226 million, compared with -$176 million in the same period of 2024. The increase in outflows was mainly due to the expansion of the scale of loan repayments. For the full year, the company optimized its debt structure through bond buybacks by subsidiaries, while reasonably managing the scale of borrowings, resulting in effective control of finance costs.

Potential Risks: Multiple External Factors Require Vigilance

2. Market Demand and Price Risk: The global crop protection industry still faces pressure from an oversupply of technical-grade active ingredients. Low prices for bulk agricultural commodities have kept farmers’ profitability under strain, and customers’ “just-in-time procurement” model will continue to affect sales cadence and inventory management.
3. Geopolitical and Tariff Risk: The company’s global headquarters is in Israel. Escalation of regional developments may have potential impacts on the supply chain. At the same time, uncertainty around global tariff policies still exists, and it is necessary to be alert to its impact on multinational supply networks.
4. Extreme Weather Risk: Extreme weather in countries such as India and Australia in 2025 has had negative impacts on sales volumes. In the future, climate change may further exacerbate uncertainty in agricultural production and affect product demand.
5. Exchange Rate Fluctuation Risk: The company’s business covers the globe. Fluctuations in the USD versus major currencies will directly affect revenue, profit, and cash flow. Significant fluctuations of the USD against currencies such as the Israeli shekel and the Turkish lira in 2025 have already produced impacts.

Compensation for Senior Management and Directors: Specific Personnel Compensation Not Disclosed

(Note: The original text does not separately disclose the total pre-tax compensation of core executives such as the chairman, general manager, vice general manager, chief financial officer, etc. It only mentions the impact of employee performance-based compensation on expenses, so no interpretation is provided.)

Click to view the full text of the announcement>>

Disclaimer: There are risks in the market; investment requires caution. This article is automatically published by an AI large model based on third-party databases and does not represent any viewpoint of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are discrepancies, please refer to the actual announcement. If you have any questions, please contact biz@staff.sina.com.cn.

A massive amount of information, precise analysis—right in the Sina Finance app

责任编辑：小浪快报